Ada Girnita - Concepedia

Author

Ada Girnita

Karolinska University Hospital

Also Known As

A Girnita, A. Girnita, Ada Girnita

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Karolinska University Hospital Karolinska Institutet University of Medicine and Pharmacy of Craiova S:t Eriks Ögonsjukhus The University of Tokyo

About

Ada Girnita is an author at Karolinska University Hospital specializing in medicine, cell signaling, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	413
2	Cell Biology	7	7	413
3	Biochemistry	1	1	73
4	Cellular Physiology	1	1	10
5	Diabetes	1	1	84

Ada Girnita

Publications

627

Citations

H-Index

Page 1

	Year	Citations
The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway Daiana Vasilcanu, Ada Girnita, Leonard Girnita, Oncogene Tyrosine PhosphorylationInsulin SignalingSignal TransductionSignaling PathwayMolecular Pathway	2004	151
RETRACTED ARTICLE:Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor Ada Girnita, Huiyuan Zheng, Alvar Grönberg, Oncogene ImmunologyCell DeathPathologyCancer BiologyInsulin Signaling	2011	84
Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and β-arrestin1 Radu Vasilcanu, D. Vasilcanu, Lars Rosengren, Oncogene Molecular PharmacologyPotential Mechanistic InvolvementMolecular PhysiologySignal TransductionBiochemistry	2007	73
Oral Picropodophyllin (PPP) Is Well Tolerated In Vivo and Inhibits IGF-1R Expression and Growth of Uveal Melanoma Mario A. Economou, Sandra Andersson, D. Vasilcanu, Investigative Ophthalmology & Visual Science	2008	54
The insulin-like growth factor-1 receptor inhibitor PPP produces only very limited resistance in tumor cells exposed to long-term selection D. Vasilcanu, W-H Weng, Ada Girnita, Oncogene Cancer ResearchGrowth HormoneLimited ResistanceLong-term SelectionTumor Cells	2005	48
Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma Claire Worrall, Naida Suleymanova, Caitrin Crudden, Oncogene	2017	36
Functional antagonism of β-arrestin isoforms balance IGF-1R expression and signalling with distinct cancer-related biological outcomes Naida Suleymanova, Caitrin Crudden, Takashi Shibano, Oncogene	2017	32
Differential roles of SS18–SSX fusion gene and insulin-like growth factor-1 receptor in synovial sarcoma cell growth Maria Törnkvist, Natalia Natalishvili, Yuntao Xie, Biochemical and Biophysical Research Communications Ss18–ssx Fusion GeneImmunologyCell ProliferationDifferential RolesCell Growth	2008	26
Inhibition of G Protein–Coupled Receptor Kinase 2 Promotes Unbiased Downregulation of IGF1 Receptor and Restrains Malignant Cell Growth Caitrin Crudden, Takashi Shibano, Dawei Song, Cancer Research	2020	23
IGF-1R tyrosine kinase expression and dependency in clones of IGF-1R knockout cells (R−) Linda Rosengren, Daiana Vasilcanu, Radu Vasilcanu, Biochemical and Biophysical Research Communications Signal TransductionSignaling PathwayCell RegulationReceptor Tyrosine KinaseIgf-1r Knockout Cells	2006	21

Page 1